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WHAT THIS PAPER ADDS
 Despite numerous attempts at devising an accurate preoperative risk score to help identify high-risk patients undergoing open
elective abdominal aortic aneurysm (AAA) repair no ideal method has been found. This paper highlights once again that there is no
model widely accepted, or repeatedly validated, in predicting mortality or cardiac events following AAA repair. In addition, the
repeated difﬁculties in risk score prediction, including geographical variation and their development based on small sample sizes,
raise the question of whether an entirely different form of stratiﬁer should be sought.a r t i c l e i n f o
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Objectives: Risk indices help quantify the risk of cardiovascular events and death prior to making decisions
about prophylactic AAA repair. This paper aims to study the predictive capabilities of 5 validated indices.
Design and methods: A prospective observational multi-centre cohort study from August 2005 to
September 2007 in Glasgow recruited 106 consecutive patients undergoing elective open AAA repair. The
Glasgow Aneurysm Score (GAS), Vascular physiology only Physiological and Operative Severity Score for
enUmeration of Mortality (V(p)-POSSUM), Vascular Biochemical and Haematological Outcome Model
(VBHOM), Revised Cardiac Risk Index (RCRI) and Preoperative Risk Score of the Estimation of Physio-
logical Ability and Surgical Stress Score (PRS of E-PASS) were calculated. Indices were compared using
receiver operating characteristic (ROC) analysis and area under the curve (AUC) estimates. End points
were all-cause mortality, Major Adverse Cardiac Events (MACE) and cardiac death.
Results: GAS, VBHOM and RCRI did not predict outcome. V(p)-POSSUM predicted MACE (AUC ¼ 0.681),
cardiac death (AUC ¼ 0.762) and all-cause mortality (AUC ¼ 0.780), as did E-PASS (AUC ¼ 0.682, 0.821,
0.703 for MACE, cardiac death and all-cause mortality respectively).
Conclusion: Whilst V(p)-POSSUM and E-PASS predicted outcome, the less complex RCRI and GAS per-
formed poorly which questions the utility of decision making based on these surgical risk indices.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Prophylactic surgical repair of an abdominal aortic aneurysm
(AAA) is associatedwith amortality of around 5e6% in theUK.1,2 The
UK small aneurysm trial comparing surgical repair with observation
of a small AAA recruited 1090 men and women aged 60e76 years
with infrarenal AAAsmeasuring 4.0e5.5 cmwhomwere considered
ﬁt for surgery. Prospective follow-up of these patients randomised
to either early surgery or routine surveillance demonstratedeneral and Vascular Surgery,
UK. Tel.:þ44 (0) 7973482206.
ce).
ciety for Vascular Surgery. Publishea greater risk of death from surgery, primarily cardiac in origin, than
in the observation group for the ﬁrst three years of follow-up.2
Survival was subsequently worse in the surveillance group so that
survival curves crossed at three years, and although this never
reached statistical signiﬁcance the importance of operative
mortality and patient selection has been underlined. Greater
discrimination of those at risk of perioperative death with poorer
short-term survival would improve management.
Several surgical risk indices have been developed to help deﬁne
the risk of perioperative death for a given patient. The Eagle3 and
Vanzetto4 scores, which use physiological factors in conjunction
with electrocardiogram (ECG) analysis and myocardial thallium
scanning, have been shown to be useful in predicting cardiac eventsd by Elsevier Ltd. All rights reserved.
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dation in predicting mortality after elective open AAA repair,5 their
need for cardiac testing make them unfavourable for preoperative
stratiﬁcation. The Leiden score andmodiﬁcations6 are unique in that
they employ a corrective factor for institution-speciﬁc mortality
rates. However the Leiden score has not consistently shown satis-
factory predictive capabilities. When applied to UK small aneurysm
trial data it predicted deathwith onlymoderate accuracy (AUC 0.72)
and was shown to have poor predictive power and calibration.7
The Estimation of Physiological Ability and Surgical Stress (E-
PASS)was found toaccuratelypredictpostoperativeoutcomeinopen
elective AAA surgery, even with the preoperative component used
alone.5,8 The Glasgow Aneurysm Score (GAS),9 Physiological and
Operative Severity Score for enumeration ofMortality (POSSUM)10,11
and Vascular Biochemical and Haematological Outcome Model
(VBHOM)12 have all been validated, showing good predictive capa-
bilities and can be used as preoperative scoring systems.13 In addi-
tion, Lee’s revised cardiac risk index (RCRI)14 predicts mortality in
vascular surgery including elective open AAA repair.15
The aim of this study is to compare ﬁve validated preoperative
risk stratiﬁcation scoring systems for patients undergoing open
elective AAA repair, and to assess their ability to predict all-cause




A prospective, observational, multi-centre cohort study was
performed involving the 3 major vascular units within Glasgow
(Gartnavel General Hospital, Glasgow Royal Inﬁrmary and the
Southern General Hospital). A cohort of consecutive patients
admitted for elective open AAA repair was identiﬁed between
August 2005 and September 2007. All patients were approached
the evening prior to surgery and informed consent obtained.
Patients were excluded if they were receiving endovascular aortic
aneurysm repair, required unplanned surgery undertaken within
less than 24 h of admission, if they were unable to give informed
consent, or if they had evidence of preoperative cardiac ischaemia
measured by preoperative ECG and cardiac troponin I (cTnI).
Patients and preoperative assessment
Demographic data and factors relating to the cardiac risk of
surgery were gathered for each patient by history and case-note
review. Collection of patient data, including preoperative blood
tests, ensured information was gathered to allow calculation of the
5 scoring systems named below. Detailed deﬁnitions are available
at the referenced publications.
Glasgow aneurysm score9
Data were collected based on:
GAS ¼ Ageþ ð17 for shockÞ þ ð7 for myocardial diseaseÞ
þ ð10 for cerebrovascular diseaseÞ
þ ð14 for renal diseaseÞ
Vascular (physiology only) e physiological and operative severity
score for enumeration of mortality11
Physiological parameters including age, presence and severity of
both cardiac and respiratory disease, ECG changes, systolic blood
pressure, pulse rate, haemoglobin, white cell count, urea, sodium,
potassium and Glasgow coma scale were collected for onlinecalculation of the V(p)-POSSUMscore at http://www.riskprediction.
org.uk/vasc-index.php. The scorewas calculated using the following
equation:
InðR=1 RÞ ¼ 8:0616þ ð0:1552 physiological scoreÞ
Vascular biochemical and haematological outcome model12
The results of preoperative plasma urea, sodium, potassium,
haemoglobin, white cell count with the addition of age or male
gender were applied to the following equation:
VBHOM ¼ lneðR=1 RÞ
¼ 2:257þ ð0:1511 sexÞ
þ ð0:9940mode of admissionÞ þ 0:05923
 age on admissionfyearsg þ ð0:001401
 ureafmmol=lgÞ þ ð  0:01303
 sodiumfmmol=lgÞ þ ð  0:03585
 potassiumfmmol=lgÞ þ ð  0:2278
 haemoglobinfg=dlgÞ þ ð0:02059
white cell countf109=lgÞ
R is the risk of death. Sex takes the value 1 for male and 0 for female,
and mode of admission takes the value 0 for elective and 1 for non-
elective admissions.
Lee’s revised cardiac risk index (RCRI)14
The RCRI was calculated by scoring one for each of; high-risk
surgery, ischaemic heart disease, congestive heart failure, cere-
brovascular disease, the use of insulin therapy for diabetes mellitus
or a preoperative creatinine level > 2 mg/dl (>176 mmol/l).
Preoperative risk score of the estimation of physiological ability and
surgical stress score8
The PRS component of the E-PASS scorewas calculated based on
the following equation:
PRS ¼ 0:0686þ 0:00345ðageÞ þ 0:323ðcardiac scoreÞ
þ 0:205ðpulmonary scoreÞ þ 0:153ðdiabetes scoreÞ
þ 0:148ðperformance status indexÞ þ 0:0666ðASAÞ
Postoperative follow-up
Postoperative screening for cardiac events was performed by
serial ECGs and cTnI measurement on the morning of the 2nd and
5th postoperative days. If a patient was due to be discharged prior to
the ﬁfth postoperative day, tests were conducted on the morning of
discharge instead of day 5. Additional postoperative investigations
were conducted at the discretion of the treating surgeon. Patients
were reviewed at an outpatient clinic 6e8 weeks post-procedure.
End points
End points for the study were MACE (non-fatal myocardial
infarction and cardiac death), cardiac death and death from any
cause. The deﬁnition of a non-fatal myocardial infarction used was
that of the Joint European Society of Cardiology/American College
of Cardiology Committee.16 Cardiac death was deﬁned as death
secondary to myocardial infarction, cardiogenic shock or intrac-
table dysrhythmia, and was determined by a review of post-
operative data by two cardiologists. If a patient had died of a non-
cardiac cause the date and cause of death were noted. If no cause of
death was noted then a death certiﬁcate review was performed.
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Statistical analysis was performed using the SPSS statistical
software package (SPSS, Chicago, Illinois, USA). Normal distributed
data were reported as mean  standard deviation. Non-parametric
data was reported as median and interquartile range.
ManneWhitney U test was used to test the differences between
non-parametric continuous variables in different subgroups. A 2-
sample t-test was used to compare continuous variables in nor-
mally distributed data. Receiver operating characteristics were
plotted and the area under the curve (AUC) estimated. A p-value
<0.05 was considered statistically signiﬁcant.
Ethical approval
Local research and development, and central ethics
committee approval was obtained for the study. All patientsTable 1
Preoperative patient characteristics and laboratory results, and their distribution accordi
All subjects (n ¼ 106) MACE (n ¼ 16)
Sex
Male 88 (83%) 13/88 (15%)
Female 18 (17%) 3/18 (17%) p ¼ 0
Angina
Present 25 (25%) 4/25 (16%)
Absent 81 (76%) 12/81 (15%) p ¼ 1
Previous MI
Present 23 (22%) 5/23 (22%)
Absent 83 (78%) 11/83 (13%) p ¼ 0
Diabetes
Present 9 (8%) 3/9 (33%)
Absent 97 (92%) 13/97 (13%) p ¼ 0
CVD
Present 22 (21%) 2/22 (9%)
Absent 84 (79%) 14/84 (17%) p ¼ 0
CCF
Present 13 (12%) 5/13 (38%)
Absent 93 (88%) 11/86 (12%) p ¼ 0
CRF
Present 8 (8%) 0/8 (0%)
Absent 98 (92%) 16/98 (16%) p ¼ 0
COPD
Present 25 (22%) 3/25 (12%)
Absent 81 (78%) 13/81 (16%) p ¼ 0
Urea (mmol/l) 7.5 (3.7)
Present 8.43 (4.48)
Absent 7.35 (3.56) p ¼
Creatinine (mmol/l) 109.2 (39.4)
Yes 116.1 (43.1)
No 107.9 (38.9) p ¼
Serum Naþ (mmol/l) 4.2 (0.48)
Yes 139.7 (1.82)
No 138.9 (2.84) p ¼
Serum Kþ (mmol/l) 139.1 (2.7)
Yes 4.14 (0.75)
No 4.22 (0.41) p ¼
Haemoglobin (g/dl) 13.3 (1.9)
Yes 12.90 (2.37)
No 13.34 (1.77) p ¼
WCC (103/ml) 7.9 (1.8)
Yes 8.43 (1.26)
No 7.79 (1.93) p ¼
Platelets (103/ml) 231.4 (83.2)
Yes 214.5 (111.2)
No 234.4 (77.6) p ¼
PT (s) 11.98 (1.94)
Yes 12.37 (2.52)
No 11.91 (1.83) p ¼
MACEemajor adverse cardiac event, MI emyocardial infarction, CVDe cerebrovascular
obstructive pulmonary disease, WCC e white cell count, PT e prothrombin time.
All laboratory variables are given as mean (SD).
All analyses performed using ﬁshers exact or a 2-sample t-test.were provided with an information sheet and had signed a study
consent form.
Results
Patient characteristics and preoperative blood testing
During the study period 111 patients met the inclusion criteria
andwere invited to participate. Two patients declined and a further
3 were found to have elevated preoperative cTnI and were not
included, resulting in 95% inclusion. None of these ﬁve patients
developed a cardiac complication or died following their proce-
dure. Themedian age of the remaining 106 patients was 73 (66e77)
years. Themale to female ratio showed amale predominance of 5:1.
The majority of patients had smoked at some point in their life
(85%) of whom 35 (33%) currently smoked. One ﬁfth of patients had
suffered a previous MI with similar numbers having suffered fromng to outcome.
Cardiac death (n ¼ 5) All-cause mortality (n ¼ 9)
5/88 (6%) 7/88 (8%)
.733 0/18 (0%) p ¼ 0.586 2/18 (11%) p ¼ 1.0
2/25 (8%) 4/25 (17%)
.0 3/81 (4%) p ¼ 0.590 5/83 (6%) p ¼ 0.210
2/23 (9%) 3/23 (13%)
.332 3/83 (4%) p ¼ 0.583 6/83 (7%) p ¼ 0.404
2/9 (22%) 2/9 (22%)
.134 3/97 (3%) p ¼ 0.056 7/97 (7%) p ¼ 0.169
2/22 (9%) 4/22 (18%)
.515 3/84 (4%) p ¼ 0.581 5/84 (6%) p ¼ 0.087
4/13 (31%) 5/13 (38%)
.026 1/86 (1%) p ¼ 0.004 4/86 (5%) p ¼ 0.011
0/8 (0%) 1/8 (13%)
.604 5/98 (5%) p ¼ 1.0 8/98 (8%) p ¼ 1.0
2/25 (8%) 3/25 (12%)
.757 3/81 (4%) p ¼ 0.590 6/81 (7%) p ¼ 0.682
10.68 (7.19) 9.98 (5.66)
0.285 7.36 (3.44) p ¼ 0.050 7.28 (3.43) p ¼ 0.037
141.2 (65.2) 131.3 (51.2)
0.450 107.6 (37.5) p ¼ 0.062 107.1 (37.8) p ¼ 0.078
139.6 (2.07) 138.8 (2.68)
0.324 139.0 (2.75) p ¼ 0.655 139.1 (2.74) p ¼ 0.741
4.24 (0.53) 4.32 (0.53)
0.558 4.21 (0.48) p ¼ 0.880 4.20 (0.47) p ¼ 0.456
11.96 (3.48) 12.14 (2.50)
0.391 13.33 (1.76) p ¼ 0.108 13.38 (1.78) p ¼ 0.058
8.08 (1.70) 8.23 (1.56)
0.208 7.88 (1.86) p ¼ 0.818 7.86 (1.88) p ¼ 0.574
146.6 (30.1) 212.2 (115.7)
0.381 235.6 (82.8) p ¼ 0.019 233.2 (80.1) p ¼ 0.473
14.2 (3.96) 12.89 (3.26)
0.382 11.87 (1.76) p ¼ 0.008 11.9 (1.78) p ¼ 0.144
disease, CCFe congestive cardiac failure, CRFe chronic renal failure, COPD e chronic
Table 2
Preoperative risk scores compared to patient outcome.
All subjects MACE Cardiac death All-cause mortality
GAS 77 (72e84)
Yes 79 (71e84) 77 (70e85) 84 (74e87)
No 71 (72e84) p ¼ 0.846 71 (72e84) p ¼ 0.911 77 (71e83) p ¼ 0.227
V(p)-POSSUM 29 (27e34)
Yes 33 (28e37) 34 (32e37) 34 (29e37)
No 29 (26e32) p ¼ 0.028 29 (26e33) p ¼ 0.030 29 (26e33) p ¼ 0.038
VBHOM 2.66 (3.07 to 2.23)
Yes 2.53 (2.96 to 2.08) 2.57 (2.78 to 1.85) 2.33 (2.62 to 2.21)
No 2.67 (3.12 to 2.26) p ¼ 0.232 2.66 (3.08 to 2.23) p ¼ 0.340 2.72 (3.10 to 2.30) p ¼ 0.069
RCRI 2 (1e3)
Yes 2 (1e3) 3 (1e4) 2 (1e4)
No 2 (1e3) p ¼ 0.735 2 (1e3) p ¼ 0.448 2 (1e3) p ¼ 0.415
PRS 0.46 (0.26e0.64)
Yes 0.63 (0.46e0.67) 0.65 (0.59e1.02) 0.65 (0.40e0.93)
No 0.42 (0.25e0.60) p ¼ 0.019 0.44 (0.26e0.62) p ¼ 0.017 0.44 (0.26e0.62) p ¼ 0.050
MACE e major adverse cardiac event, GAS e Glasgow aneurysm score, V(p)-POSSUM e physiological component of vascular physiological and operative severity score for
enumeration ofmortality, VBHOMe vascular biochemical and haematological outcomemodel, RCRIe revised cardiac risk index, PRSe preoperative risk score of estimation of
physiological ability and surgical stress.
All scores recorded as median (interquartile range).
All analyses performed using ManneWhitney U test.
G.J. Bryce et al. / European Journal of Vascular and Endovascular Surgery 44 (2012) 55e6158cerebrovascular disease. Other patient characteristics are detailed
in Table 1. The majority of laboratory variables were within normal
reference ranges for the local population [Table 1].
Risk indices and outcome
Complete datasets required for the calculation of all 5
preoperative risk indices were collected in all 106 patients. Of
these 16 (15%) suffered MACE within 30 days, of whom 5
patients suffered a cardiac death and 11 had a non-fatal MI. The
30-day all-cause postoperative mortality was 8.5% (9 deaths), of
which 7 deaths occurred prior to hospital discharge (6.6% in-
hospital mortality).
Platelet levels and prothrombin times were signiﬁcantly higher
in those that suffered a cardiac death (p ¼ 0.019 and p ¼ 0.008
respectively) on univariate analysis. Serum urea was signiﬁcantly
higher in patients who died from all-cause mortality (p ¼ 0.037).
Urea levels were also higher in those who suffered cardiac death,
although this was not signiﬁcant (p ¼ 0.050). Haemoglobin levelsTable 3
Results of receiver operating characteristic curve analysis for each score according to ou
AUC 95% CI SE p-Valu
MACE
GAS 0.515 0.374e0.657 0.072 0.846
V(p)-POSSUM 0.681 0.549e0.814 0.067 0.021
VBHOM 0.592 0.455e0.730 0.070 0.241
RCRI 0.525 0.364e0.687 0.082 0.747
PRS 0.682 0.559e0.805 0.063 0.021
Cardiac death
GAS 0.515 0.285e0.745 0.117 0.911
V(p)-POSSUM 0.762 0.596e0.928 0.085 0.048
VBHOM 0.626 0.430e0.822 0.100 0.344
RCRI 0.596 0.285e0.907 0.159 0.470
PRS 0.821 0.697e0.945 0.063 0.016
All-cause mortality
GAS 0.622 0.436e0.808 0.095 0.227
V(p)-POSSUM 0.780 0.667e0.893 0.057 0.006
VBHOM 0.684 0.555e0.813 0.066 0.069
RCRI 0.578 0.361e0.796 0.111 0.438
PRS 0.703 0.516e0.890 0.095 0.045
MACE e major adverse cardiac event, GAS e Glasgow aneurysm score, V(p)-POSSUM e
enumeration ofmortality, VBHOMe vascular biochemical and haematological outcomem
physiological ability and surgical stress, AUC e area under the curve, CI e conﬁdence i
predictive value, NPV e negative predictive value.were lower in those that died of all-cause mortality, although again
this was not signiﬁcant (p ¼ 0.058).
Glasgow aneurysm score, vascular biochemical and haematological
outcome model and Lee’s revised cardiac risk index
The median GAS, VBHOM and RCRI scores were not signiﬁcantly
different in those patients who suffered MACE, cardiac death, or in
those who died of all-cause mortality [Table 2]. ROC analysis
revealed low accuracy in predicting MACE, cardiac death and all-
cause mortality for all 3 scores. Sensitivities and speciﬁcities were
poor and all 3 scores appeared to perform poorly in all outcome
measures [Table 3].
Vascular (physiology only) e physiological and operative severity
score for enumeration of mortality
There was a difference in median V(p)-POSSUM with higher
scores in those who suffered MACE (p ¼ 0.028), cardiac death
(p¼ 0.030), and in thosewho died of all-causemortality (p¼ 0.038)
[Table 2]. ROC analysis revealed an AUC of 0.681 in predictingMACEtcome.
e Cut-off Sens. Spec. PPV NPV
77.5 50% 53% 14% 86%
20.5 63% 67% 35% 93%
2.59 56% 56% 16% 88%
>1 63% 38% 15% 85%
0.55 69% 64% 27% 93%
76.5 60% 46% 5.2% 96%
20.5 80% 65% 15% 99%
2.59 60% 56% 5% 96%
>2 60% 68% 9% 97%
0.63 80% 76% 15% 99%
77.5 56% 54% 10% 93%
20.5 89% 68% 21% 99%
2.48 67% 73% 15% 95%
>2 45% 68% 11% 93%
0.55 78% 63% 15% 97%
physiological component of vascular physiological and operative severity score for
odel, RCRIe revised cardiac risk index, PRSe preoperative risk score of estimation of










































































Figure 2. Tertile analysis for individual risk scores. MACE e major adverse cardiac
event, V(p)-POSSUM e physiological component of vascular physiological and opera-
tive severity score for enumeration of mortality, PRS e preoperative risk score of
estimation of physiological ability and surgical stress. All analyses were performed
using ManneWhitney U test.
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predicting cardiac death and an AUC of 0.780 for predicting all-
cause mortality, with once again a cut-off of 20.5 for both
outcome measures [Table 3].
Preoperative risk score of the estimation of physiological ability and
surgical stress score
The median PRS was higher in those who suffered MACE
(p ¼ 0.019) and cardiac death (p ¼ 0.017). The median PRS was
higher in the all-cause mortality group than in the survivors,
although this was just not signiﬁcant (p ¼ 0.050) [Table 2]. ROC
analysis revealed an AUC of 0.682 in predicting MACE and 0.703 in
predicting all-cause mortality, with a cut-off of 0.55 for both
outcome measures. ROC analysis revealed an AUC of 0.821 for
predicting cardiac death [Fig. 1] with a cut-off of 0.63 [Table 3].
Tertile analyses of risk indices
Tertile analysis was performed by dividing each index grouping
into 3 equal classes based on even distribution with the aim of
examining stepwise increase in MACE, cardiac death and mortality
between groups. For GAS (p ¼ 0.584, p ¼ 0.891 and p ¼ 0.264
respectively), VBHOM (p¼ 0.395, p¼ 0.174 and p¼ 0.070) and RCRI
(p ¼ 1.0, p ¼ 0.368 and p ¼ 0.867) there were no signiﬁcant
differences in the tertile rates of MACE, cardiac death and all-cause
mortality.
For V(p)-POSSUM sequential increases were seen in rates for
MACE and all-cause mortality with rates in MACE of 4%, 13% and
29%, and in all-cause mortality of 0%, 8% and 16% (p ¼ 0.013 and
p ¼ 0.030 respectively). In cardiac death there was no signiﬁcant
rate change between tertiles with rates of 0%, 4% and 10%
(p ¼ 0.130) [Fig. 2a].
For the PRS component of E-PASS there were signiﬁcant
increases in rates for all outcome measures with rates of 6%, 13%
and 27% in MACE, 0%, 3% and 12% in cardiac death, and rates of
6%, 3% and 18% in all-cause mortality (p ¼ 0.038, p ¼ 0.015 and
p ¼ 0.032 respectively) [Fig. 2b].Figure 1. Receiver operating characteristics curve for PRS and cardiac death with an
area under the curve of 0.821.Discussion
Preoperative risk stratiﬁcation is of importance in elective open
AAA repair and, since opinion and experience alone are often the
only tools of the vascular surgeon in selecting operative candidates,
an optimal risk stratiﬁer has been sought. A number of risk scoring
systems derived from patients undergoing non-cardiac surgery
have been devised, but most seem to lack accuracy.13e15 Based on
a review of the literature, the 5 most suitable preoperative risk
scoring indices have been identiﬁed and prospectively evaluated
with an emphasis on predicting MACE, cardiac death and all-cause
mortality in the immediate postoperative period.
The two scoring systems that performed well were V(p)-
POSSUM and the Preoperative Risk Score component of E-PASS.
In this cohort, the physiology component of V(p)-POSSUM was
a signiﬁcant predictor of all outcome measures. POSSUM scoring
has long been advocated as the most ﬁtting scoring system in non-
cardiac surgery.17 This may be due to the inclusion of a relatively
high number of important serum and physiological markers,
providing a more detailed account of physiological reserve.
However, POSSUM has been shown to over-predict death in low
risk patients,18 despite modiﬁcation including the vascular adap-
tion.19 It is therefore expected that V(p)-POSSUM would perform
well in predicting all-cause mortality in the elective open AAA
patient, given the higher risk associated with this surgery type
compared to other types of non-cardiac and vascular procedures. It
was an unexpected ﬁnding that it would performwell in predicting
MACE, although this may reﬂect its ability to predict morbidity in
general. Whilst this index appears to perform well, there is over-
riding concern with the effect of area-wide variation, and whilst
V(p)-POSSUM allows for variations in the hospital case mix it is not
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development as that of an audit tool including operative data
continues to raise questions about its use in the preoperative
setting when guiding clinical decision making.
The PRS component of the E-PASS score predicted MACE and
cardiac death, and whilst it did not appear to predict all-cause
mortality on univariate testing it did perform well on tertile anal-
ysis and in ROC curve analysis. The main concern with E-PASS is
that the original scoring system requires operative data to calculate
its overall score thus precluding its use for preoperative risk
assessment. However a strong correlation between the PRS
component and outcome has been shownwhich therefore permits
its use in the preoperative setting.8 It may be the very premise of
this scoring system, where each patient’s physiological reserve is
scored, that gives a more accurate outcome measure.
Of the other scoring systems only VBHOM showed utility in
predicting all-cause mortality. However, this did not reach statis-
tical signiﬁcance and VBHOMperformed poorly in predictingMACE
or cardiac death. This conﬁrms previous validations where VBHOM
was shown to under-predict perioperative complications and over-
predict mortality.17 This may be explained by the fact that VBHOM
was devised including patients who underwent emergency AAA
repair.
The GAS and RCRI performed poorly in this prospective cohort.
The GAS was constructed using a population of 500 patients
undergoing both emergency and elective AAA repair in Glasgow
over a 10 year period between 1980 and 1990.9 This was a retro-
spective data analysis and produced a simple index of risk. Despite
numerous validations in different populations21e25 the GAS has
been criticised for not reliably identifying individual high-risk
patients and being consistently inaccurate in predicting
morbidity,5,24 whilst also performing poorly when compared to
other scoring systems.5 The GAS also fails to allow for treatment or
optimisation of a patient’s comorbid condition and scores for the
presence of disease rather than the functional effects of the disease
process. More surprising is that the score is a poor predictor in the
very population from which it was derived, which may be in part
explained by the increasing age and improving health states of the
population.
The most unexpected ﬁnding is that the RCRI performed worst.
As the only score of the 5 included that was speciﬁcally designed to
evaluate cardiac risk it is unexpected that it not only failed to
predict mortality but also failed to predict cardiac events. This lack
of predictive value may be due to the high-risk population within
which it was used, immediately scoring every patient 1 prior to
further scoring. It is likely that this diminishes the sensitivity of the
index, as has been suggested in the published literature, where
concern has been expressed at the grouping of intraperitoneal and
major vascular surgery together, and where open AAA repair has
shown to have worse outcome than all other operation subgroups
that are considered together in the RCRI.26,27 This lack of sub-
grouping is taken into account in the ESC/ESA Guidelines for
preoperative cardiac risk assessment and perioperative cardiac
management in non-cardiac surgery.28 This may improve the
accuracy of the RCRI, which plays a key role in the algorithm
proposed by Poldermans et al. The results of this study do however
raise concern about the use of these guidelines in open elective AAA
repair.
The principal limitation of this prospective cohort is the small
sample size. Although MACE occurred with sufﬁcient frequency to
draw reasonable conclusions, all-cause mortality and in particular
cardiac death were low in absolute numbers. A larger cohort would
have been more conducive to risk estimation. In contrast, however,
the end points were well-deﬁned and most vascular surgical
practices will deal with numbers similar to this cohort. Thistherefore questions the utility of scoring systems that require large
numbers to be clinically relevant.
In conclusion, it appears both the PRS component of E-PASS and
V(p)-POSSUM have advantages in predicting outcome following
elective open AAA repair over other scoring systems. Whilst V(p)-
POSSUM appears to be the best stratiﬁcation score (and easily
accessible on the internet) with regard to all-cause mortality, its
inability to predict mortality rates in individual patients may make
E-PASS a more favourable alternative, having been developed
speciﬁcally as an aid to clinical decision making, although further
validation is required.13,29 Both the RCRI and GAS lacked predictive
power. As the simplest forms of risk score these are possibly the
most often used in the clinical environment, and the results are
therefore disappointing for real life clinical practice. The increas-
ingly aged population with greater use of medical therapy and
synchronous rise in EVAR may mean that more up to date indices
such as the customised probability model30 or other risk prediction
models31,32 will show greater predictive abilities, however these
await widespread validation and acceptance in risk assessing for
open elective AAA repair. Based on the results of this study it would
be advisable not to base clinical decision making in aneurysm
surgery on RCRI or GAS scoring. Further, the complexity of those
scores that do show predictive abilities make their use in the
clinical setting on an individual patient basis debatable, and it may
be these scores should remain audit tools rather than tools on
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